TY - JOUR
T1 - Illuminating the Molecular Intricacies of Exosomes and ncRNAs in Cardiovascular Diseases
T2 - Prospective Therapeutic and Biomarker Potential
AU - Khan, Farheen Badrealam
AU - Uddin, Shahab
AU - Elderdery, Abozer Y.
AU - Goh, Khang Wen
AU - Ming, Long Chiau
AU - Ardianto, Chrismawan
AU - Palakot, Abdul Rasheed
AU - Anwar, Irfa
AU - Khan, Mohsina
AU - Owais, Mohammad
AU - Huang, Chih Yang
AU - Daddam, Jayasimha Rayalu
AU - Khan, Meraj Alam
AU - Shoaib, Shoaib
AU - Khursheed, Md
AU - Reshadat, Sara
AU - Khayat Kashani, Hamid Reza
AU - Mirza, Sameer
AU - Khaleel, Abbas A.
AU - Ayoub, Mohammed Akli
N1 - Publisher Copyright:
© 2022 by the authors.
PY - 2022/11
Y1 - 2022/11
N2 - Cardiovascular diseases (CVDs) are one of the leading causes of death worldwide. Accumulating evidences have highlighted the importance of exosomes and non-coding RNAs (ncRNAs) in cardiac physiology and pathology. It is in general consensus that exosomes and ncRNAs play a crucial role in the maintenance of normal cellular function; and interestingly it is envisaged that their potential as prospective therapeutic candidates and biomarkers are increasing rapidly. Considering all these aspects, this review provides a comprehensive overview of the recent understanding of exosomes and ncRNAs in CVDs. We provide a great deal of discussion regarding their role in the cardiovascular system, together with providing a glimpse of ideas regarding strategies exploited to harness their potential as a therapeutic intervention and prospective biomarker against CVDs. Thus, it could be envisaged that a thorough understanding of the intricacies related to exosomes and ncRNA would seemingly allow their full exploration and may lead clinical settings to become a reality in near future.
AB - Cardiovascular diseases (CVDs) are one of the leading causes of death worldwide. Accumulating evidences have highlighted the importance of exosomes and non-coding RNAs (ncRNAs) in cardiac physiology and pathology. It is in general consensus that exosomes and ncRNAs play a crucial role in the maintenance of normal cellular function; and interestingly it is envisaged that their potential as prospective therapeutic candidates and biomarkers are increasing rapidly. Considering all these aspects, this review provides a comprehensive overview of the recent understanding of exosomes and ncRNAs in CVDs. We provide a great deal of discussion regarding their role in the cardiovascular system, together with providing a glimpse of ideas regarding strategies exploited to harness their potential as a therapeutic intervention and prospective biomarker against CVDs. Thus, it could be envisaged that a thorough understanding of the intricacies related to exosomes and ncRNA would seemingly allow their full exploration and may lead clinical settings to become a reality in near future.
KW - cardiovascular disease
KW - circRNA
KW - exosomes
KW - lncRNA
KW - miRNA
KW - ncRNA
UR - http://www.scopus.com/inward/record.url?scp=85142417726&partnerID=8YFLogxK
U2 - 10.3390/cells11223664
DO - 10.3390/cells11223664
M3 - Review article
AN - SCOPUS:85142417726
SN - 2073-4409
VL - 11
JO - Cells
JF - Cells
IS - 22
M1 - 3664
ER -